In this project, by analyzing data from public databases and performing the immunohistochemical staining of clinical specimens, the level of IGF2BP2 was verified to be remarkably improved in gastric cancer tissues, and its overexpression predicted worse survival for GC patients. Here, IGF2BP2 is linked to gastric cancer.